[Bonuslist] [EXTERNAL] Fwd: PLEASE TAKE ACTION - Share your article [NIMA_169190]

Mon Feb 19 19:52:28 EST 2024

Dear all,
     The NIM paper is officially published. Congratulations on this
achievement. Looking forward to the next PRLs.

Best regards,
Mohammad Hattawy.

---------- Forwarded message ---------
From: Elsevier - Article Status <Article_Status at elsevier.com>
Date: Mon, Feb 19, 2024 at 19:46
Subject: PLEASE TAKE ACTION - Share your article [NIMA_169190]
To: <mohammad.hattawy at gmail.com>

[image: Elsevier] <https://urldefense.proofpoint.com/v2/url?u=http-3A__www.elsevier.com_&d=DwIFaQ&c=CJqEzB1piLOyyvZjb8YUQw&r=CJm6DhRcoX04MjTsHQ1rOaz5dKcjlcAdQlzenFZzaP4&m=oo_lak0oIO0hDVrfe_kXQ3nGWgdtZsaSqSWr3qPJ0lBofcRRaDh85UZoMtE-m8iz&s=3vNFT6IeiQ41ptSPrzNxNWPUXZrqE31wnNPY_aOSim8&e= >
Share your article!
[image: banner]

Title: *Design, Construction, and Performance of the GEM based Radial Time
Projection Chamber for the BONuS12 Experiment with CLAS12*
Reference: *NIMA_169190*

[image: cover] <https://urldefense.proofpoint.com/v2/url?u=https-3A__www.elsevier.com_locate_issn_0168-2D9002&d=DwIFaQ&c=CJqEzB1piLOyyvZjb8YUQw&r=CJm6DhRcoX04MjTsHQ1rOaz5dKcjlcAdQlzenFZzaP4&m=oo_lak0oIO0hDVrfe_kXQ3nGWgdtZsaSqSWr3qPJ0lBofcRRaDh85UZoMtE-m8iz&s=98eVhypi6IT4cPKfbjGvrohWcO9jU6RHW9ctMNZFf6I&e= >

Dear Dr. Hattawy,

We are pleased to let you know that the final version of your article *Design,
Construction, and Performance of the GEM based Radial Time Projection
Chamber for the BONuS12 Experiment with CLAS12* is now available online,
containing full bibliographic details. Are you ready to share it with the
world?

To help you access and share this work, we have created a Share Link – a
personalized URL providing *50 days' free access* to your article. Anyone
clicking on this link before April 10, 2024 will be taken directly to the
final version of your article on ScienceDirect, which they are welcome to
read or download. No sign up, registration or fees are required.

Your personalized Share Link:
https://urldefense.proofpoint.com/v2/url?u=https-3A__authors.elsevier.com_a_1idTAcPqbsgID&d=DwIFaQ&c=CJqEzB1piLOyyvZjb8YUQw&r=CJm6DhRcoX04MjTsHQ1rOaz5dKcjlcAdQlzenFZzaP4&m=oo_lak0oIO0hDVrfe_kXQ3nGWgdtZsaSqSWr3qPJ0lBofcRRaDh85UZoMtE-m8iz&s=y_6uNh7aAqo3ixZUus7L6ltIy_pcjal6xaajBok68p8&e= 

We encourage you to use this Share Link to download a copy of the article
for your own archive. The URL is also a quick and easy way to share your
work with colleagues, co-authors and friends. And you are welcome to add
the Share Link to your homepage or social media profiles, such as Facebook
and Twitter.

You can find out more about Share Links on Elsevier.com
<https://urldefense.proofpoint.com/v2/url?u=https-3A__www.elsevier.com_authors_journal-2Dauthors_submit-2Dyour-2Dpaper_sharing-2Dand-2Dpromoting-2Dyour-2Darticle_share-2Dlink&d=DwIFaQ&c=CJqEzB1piLOyyvZjb8YUQw&r=CJm6DhRcoX04MjTsHQ1rOaz5dKcjlcAdQlzenFZzaP4&m=oo_lak0oIO0hDVrfe_kXQ3nGWgdtZsaSqSWr3qPJ0lBofcRRaDh85UZoMtE-m8iz&s=DZit4xXoN9yApIhoWd9s5bMztj5OX4DJjaxIi5Lrbhs&e= >
.

Did you know, as an author, you can use your article for a wide range of
scholarly, non-commercial purposes, and share and post your article online
in a variety of ways? For more information visit
https://urldefense.proofpoint.com/v2/url?u=http-3A__www.elsevier.com_sharing-2Darticles&d=DwIFaQ&c=CJqEzB1piLOyyvZjb8YUQw&r=CJm6DhRcoX04MjTsHQ1rOaz5dKcjlcAdQlzenFZzaP4&m=oo_lak0oIO0hDVrfe_kXQ3nGWgdtZsaSqSWr3qPJ0lBofcRRaDh85UZoMtE-m8iz&s=I0EF654bjjeAPIqvxsyPLqDn1fih4McT-ozYL5qid5I&e= .

Kind regards,

Elsevier Researcher Support

For further help and/or information please visit our Author hub here
<https://urldefense.proofpoint.com/v2/url?u=https-3A__service.elsevier.com_app_answers_detail_a-5Fid_34514_c_10532_supporthub_publishing_&d=DwIFaQ&c=CJqEzB1piLOyyvZjb8YUQw&r=CJm6DhRcoX04MjTsHQ1rOaz5dKcjlcAdQlzenFZzaP4&m=oo_lak0oIO0hDVrfe_kXQ3nGWgdtZsaSqSWr3qPJ0lBofcRRaDh85UZoMtE-m8iz&s=2w5XFkuj_Pz6qs4TJuxpdjwe86ZKEEMUB38K7CFTejM&e= >
.

*Increase your article's impact*
Our Get Noticed
<https://urldefense.proofpoint.com/v2/url?u=https-3A__www.elsevier.com_-5F-5Fdata_assets_pdf-5Ffile_0014_201326_Get-2DNoticed-2DLeaflet-2DDecember-2D2020.pdf&d=DwIFaQ&c=CJqEzB1piLOyyvZjb8YUQw&r=CJm6DhRcoX04MjTsHQ1rOaz5dKcjlcAdQlzenFZzaP4&m=oo_lak0oIO0hDVrfe_kXQ3nGWgdtZsaSqSWr3qPJ0lBofcRRaDh85UZoMtE-m8iz&s=4p2UxEc8X2nXy8tQkea1tcxDcEnd8YJCL9Z-NyoZk2Y&e= >
guide contains a range of practical tips and advice to help you maximize
visibility of your article.

*Publishing Lab*
Do you have ideas on how we can improve the author experience? Sign up for
the Elsevier Publishing Lab <https://urldefense.proofpoint.com/v2/url?u=http-3A__www.elsevier.com_publishing-2Dlab&d=DwIFaQ&c=CJqEzB1piLOyyvZjb8YUQw&r=CJm6DhRcoX04MjTsHQ1rOaz5dKcjlcAdQlzenFZzaP4&m=oo_lak0oIO0hDVrfe_kXQ3nGWgdtZsaSqSWr3qPJ0lBofcRRaDh85UZoMtE-m8iz&s=lEVrSI00lE8omlZWv0vOQ1GUkz2m7oUPhRu6SjjKYwg&e= > and
help us develop our publishing innovations!

*Have questions or need assistance?*
Please do not reply to this automated message.
For further assistance, please visit our Elsevier Support Center
<https://urldefense.proofpoint.com/v2/url?u=https-3A__service.elsevier.com_app_home_supporthub_publishing_&d=DwIFaQ&c=CJqEzB1piLOyyvZjb8YUQw&r=CJm6DhRcoX04MjTsHQ1rOaz5dKcjlcAdQlzenFZzaP4&m=oo_lak0oIO0hDVrfe_kXQ3nGWgdtZsaSqSWr3qPJ0lBofcRRaDh85UZoMtE-m8iz&s=SOvJyPauqTWcNPA3v7xuuQWLs5mrXoDjFvF-GzjtfoY&e= > where you
can search for solutions on a range of topics and find answers to
frequently asked questions.
>From here you can also contact our Researcher Support team via 24/7 live
chat, email or phone support.

*© 2024 Elsevier Ltd | Privacy Policy* https://urldefense.proofpoint.com/v2/url?u=http-3A__www.elsevier.com_privacypolicy&d=DwIFaQ&c=CJqEzB1piLOyyvZjb8YUQw&r=CJm6DhRcoX04MjTsHQ1rOaz5dKcjlcAdQlzenFZzaP4&m=oo_lak0oIO0hDVrfe_kXQ3nGWgdtZsaSqSWr3qPJ0lBofcRRaDh85UZoMtE-m8iz&s=VJ5rKCDWnhTOZPOlQkDQNcW4oHsl8NbfcOzUPzUluWY&e= 
Elsevier Limited, 125 London Wall, London, EC2Y 5AS, United Kingdom
<https://urldefense.proofpoint.com/v2/url?u=https-3A__www.google.com_maps_search_125-2BLondon-2BWall-2C-2BLondon-2C-2BEC2Y-2B5AS-2C-2BUnited-2BKingdom-3Fentry-3Dgmail-26source-3Dg&d=DwIFaQ&c=CJqEzB1piLOyyvZjb8YUQw&r=CJm6DhRcoX04MjTsHQ1rOaz5dKcjlcAdQlzenFZzaP4&m=oo_lak0oIO0hDVrfe_kXQ3nGWgdtZsaSqSWr3qPJ0lBofcRRaDh85UZoMtE-m8iz&s=o4two9UpaU3z56-bzrl8evI0oXD7LKlLERVggII8dZI&e= >,
Registration No. 1982084. This e-mail has been sent to you from Elsevier
Ltd. To ensure delivery to your inbox (not bulk or junk folders), please
add Article_Status at elsevier.com to your address book or safe senders list.
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <https://mailman.jlab.org/pipermail/bonuslist/attachments/20240219/0ae2c30f/attachment-0001.html>